Pharmaxis Strengthens Drug Discovery Capability as its Technology Platform Continues to Deliver
19th Oct 17
Release Date: 19/10/2017 12:26pm
- Head of Chemistry (ex Boehringer Ingelheim) recruited to Drug Discovery leadership team
- Two leading scientists join Scientific Advisory Board
- Amine Oxidase chemistry platform delivers five lead candidates in fibrosis and inflammation over four years as Pharmaxis states ambition to expand its drug discovery activities into new technologies and take select programs into phase 2 clinical trials.
Categories: News and Media